102 related articles for article (PubMed ID: 17052926)
1. Magnetic resonance imaging to identify classic and nonclassic forms of ferroportin disease.
Pietrangelo A; Corradini E; Ferrara F; Vegetti A; De Jong G; Luca Abbati G; Paolo Arcuri P; Martinelli S; Cerofolini E
Blood Cells Mol Dis; 2006; 37(3):192-6. PubMed ID: 17052926
[TBL] [Abstract][Full Text] [Related]
2. The ferroportin disease.
Pietrangelo A
Blood Cells Mol Dis; 2004; 32(1):131-8. PubMed ID: 14757427
[TBL] [Abstract][Full Text] [Related]
3. Identification of mutations in SLC40A1 that affect ferroportin function and phenotype of human ferroportin iron overload.
Mayr R; Griffiths WJ; Hermann M; McFarlane I; Halsall DJ; Finkenstedt A; Douds A; Davies SE; Janecke AR; Vogel W; Cox TM; Zoller H
Gastroenterology; 2011 Jun; 140(7):2056-63, 2063.e1. PubMed ID: 21396368
[TBL] [Abstract][Full Text] [Related]
4. Primary iron overload with inappropriate hepcidin expression in V162del ferroportin disease.
Zoller H; McFarlane I; Theurl I; Stadlmann S; Nemeth E; Oxley D; Ganz T; Halsall DJ; Cox TM; Vogel W
Hepatology; 2005 Aug; 42(2):466-72. PubMed ID: 15986403
[TBL] [Abstract][Full Text] [Related]
5. G80S-linked ferroportin disease: the first clinical description in a Greek family.
Mougiou A; Pietrangelo A; Caleffi A; Kourakli A; Karakantza M; Zoumbos N
Blood Cells Mol Dis; 2008; 41(1):138-9. PubMed ID: 18420432
[No Abstract] [Full Text] [Related]
6. A novel mutation in the SLC40A1 gene associated with reduced iron export in vitro.
Moreno-Carralero MI; Muñoz-Muñoz JA; Cuadrado-Grande N; López-Rodríguez R; José Hernández-Alfaro M; del-Castillo-Rueda A; Enríquez-de-Salamanca R; Méndez M; Morán-Jiménez MJ
Am J Hematol; 2014 Jul; 89(7):689-94. PubMed ID: 24644245
[TBL] [Abstract][Full Text] [Related]
7. G80S-linked ferroportin disease: classical ferroportin disease in an Asian family and reclassification of the mutant as iron transport defective.
McDonald CJ; Wallace DF; Ostini L; Bell SJ; Demediuk B; Subramaniam VN
J Hepatol; 2011 Mar; 54(3):538-44. PubMed ID: 21094556
[TBL] [Abstract][Full Text] [Related]
8. Phenotypic expression of ferroportin disease in a family with the N144H mutation.
Rosmorduc O; Wendum D; Arrivé L; Elnaggar A; Ennibi K; Hannoun L; Charlotte F; Grangé JD; Poupon R
Gastroenterol Clin Biol; 2008 Mar; 32(3):321-7. PubMed ID: 18403150
[TBL] [Abstract][Full Text] [Related]
9. Ferroportin disease: pathogenesis, diagnosis and treatment.
Pietrangelo A
Haematologica; 2017 Dec; 102(12):1972-1984. PubMed ID: 29101207
[TBL] [Abstract][Full Text] [Related]
10. Iron overload due to mutations in ferroportin.
De Domenico I; Ward DM; Musci G; Kaplan J
Haematologica; 2006 Jan; 91(1):92-5. PubMed ID: 16434376
[TBL] [Abstract][Full Text] [Related]
11. Ferroportin disease: a systematic meta-analysis of clinical and molecular findings.
Mayr R; Janecke AR; Schranz M; Griffiths WJ; Vogel W; Pietrangelo A; Zoller H
J Hepatol; 2010 Nov; 53(5):941-9. PubMed ID: 20691492
[TBL] [Abstract][Full Text] [Related]
12. Iron overload in Africans and African-Americans and a common mutation in the SCL40A1 (ferroportin 1) gene.
Gordeuk VR; Caleffi A; Corradini E; Ferrara F; Jones RA; Castro O; Onyekwere O; Kittles R; Pignatti E; Montosi G; Garuti C; Gangaidzo IT; Gomo ZA; Moyo VM; Rouault TA; MacPhail P; Pietrangelo A
Blood Cells Mol Dis; 2003; 31(3):299-304. PubMed ID: 14636642
[TBL] [Abstract][Full Text] [Related]
13. Bone marrow iron distribution, hepcidin, and ferroportin expression in renal anemia.
Bârsan L; Stanciu A; Stancu S; Căpuşă C; Brătescu L; Mandache E; Radu E; Mircescu G
Hematology; 2015 Oct; 20(9):543-52. PubMed ID: 25745821
[TBL] [Abstract][Full Text] [Related]
14. A novel mutation in ferroportin implicated in iron overload.
Wallace DF; Dixon JL; Ramm GA; Anderson GJ; Powell LW; Subramaniam VN
J Hepatol; 2007 May; 46(5):921-6. PubMed ID: 17383046
[TBL] [Abstract][Full Text] [Related]
15. Functional analysis and theoretical modeling of ferroportin reveals clustering of mutations according to phenotype.
Wallace DF; Harris JM; Subramaniam VN
Am J Physiol Cell Physiol; 2010 Jan; 298(1):C75-84. PubMed ID: 19846751
[TBL] [Abstract][Full Text] [Related]
16. Molecular and clinical correlates in iron overload associated with mutations in ferroportin.
De Domenico I; McVey Ward D; Nemeth E; Ganz T; Corradini E; Ferrara F; Musci G; Pietrangelo A; Kaplan J
Haematologica; 2006 Aug; 91(8):1092-5. PubMed ID: 16885049
[TBL] [Abstract][Full Text] [Related]
17. Hepatic iron concentration, fibrosis and response to venesection associated with the A77D and V162del "loss of function" mutations in ferroportin disease.
Lim FL; Dooley JS; Roques AW; Grellier L; Dhillon AP; Walker AP
Blood Cells Mol Dis; 2008; 40(3):328-33. PubMed ID: 18160317
[TBL] [Abstract][Full Text] [Related]
18. Impaired iron transport activity of ferroportin 1 in hereditary iron overload.
McGregor JA; Shayeghi M; Vulpe CD; Anderson GJ; Pietrangelo A; Simpson RJ; McKie AT
J Membr Biol; 2005 Jul; 206(1):3-7. PubMed ID: 16440176
[TBL] [Abstract][Full Text] [Related]
19. Monitoring of hepcidin levels in a patient with G80S-linked ferroportin disease undergoing iron depletion by phlebotomy.
Wolff F; Bailly B; Gulbis B; Cotton F
Clin Chim Acta; 2014 Mar; 430():20-1. PubMed ID: 24370385
[No Abstract] [Full Text] [Related]
20. The impact of the mutations of the HFE gene and of the SLC11A3 gene on iron overload in Greek thalassemia intermedia and beta(s)/beta(thal) anemia patients.
Politou M; Kalotychou V; Pissia M; Rombos Y; Sakellaropoulos N; Papanikolaou G
Haematologica; 2004 Apr; 89(4):490-2. PubMed ID: 15075083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
